SmileDirectClub Partners With Unified Smiles
New Partnership With Leading Dental Support Organization Increases Consumer Choice And Delivers Option To Begin SmileDirectClub Aligner Treatment At Dentists’...
New Partnership With Leading Dental Support Organization Increases Consumer Choice And Delivers Option To Begin SmileDirectClub Aligner Treatment At Dentists’...
High-throughput clinical assay detects and quantifies SARS-CoV-2 neutralizing antibodies ROCHESTER, Minn., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Imanis Life Sciences,...
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical...
MOUNTAIN VIEW, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D.,...
Strengthens balance sheet with a 50% reduction in 2022 cash obligation and extended term on remaining balance TORONTO, Nov. 19,...
$2.5 million upfront for the Ii-Key-H1 vaccine from NuGenerex-Immuno-Oncology (NGIO) and to initiate epitope identification for Ii-Key vaccine development against...
Weill Cornell Medicine Researchers Utilize Fluidigm Hyperion Imaging System to Identify a Phenotype of Immune Cell Activity Distinct from Other...
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR), an investment company with innovative medical instrumentation...
RenovaCare Intellectual Property Update RenovaCare Awarded New Patents for SkinGun™: Ultra-Gentle Cell Spray Technology ROSELAND, N.J., Nov. 19, 2020 (GLOBE...
Candidate Therapy for Flu+Covid-19 Co-infection Shows Potent Anti-Viral Potential AUSTIN, Texas, Nov. 19, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:...
Upcoming Vaccines Increase the Need for Ongoing Monitoring of Presence and Durability of Immunity Mountain View, CA , Nov. 19,...
Capital increase in connection with exercise of warrants Ambu A/S issued 770,000 warrants in 2015, and 419,500 warrants in November...
Advisory Council to collaborate on outreach to retinal clinicians to support development and commercialization of ONS-5010, an investigational ophthalmic formulation...
CAMBRIDGE, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel...
REDWOOD CITY, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq:RZLT), a clinical stage biopharmaceutical company dedicated to advancing...
BURLINGTON, Mass., Nov. 19, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing...
Investigational drug RNL™ delivers up to fifteen times the absorbed dose of radiation compared to standard external beam radiation therapy...
NEW YORK, Nov. 19, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the “Company” or “BeyondSpring”) (Nasdaq: BYSI), a global biopharmaceutical company...
GARDEN CITY, N.Y., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical...
SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue) announced today that, as of November 9, the...